Key Highlights
- Lam Research (LRCX) achieved a new record peak of $274.42, surging 262% year-over-year
- Third-quarter fiscal results exceeded projections; fourth-quarter outlook also surpassed analyst expectations
- TD Cowen boosted its price objective to $340 from $290, reaffirming a Buy recommendation
- Multiple firms including UBS, Stifel, RBC, Cantor Fitzgerald, and TD Cowen maintain Buy or Overweight stances
- Management confirmed the firm has already achieved its financial targets originally set for 2028 and beyond
Shares of Lam Research (LRCX) reached an unprecedented high of $274.42 during Thursday’s trading session, marking the culmination of a remarkable 12-month period that saw the equity appreciate over 262%.
Lam Research Corporation, LRCX
Data from InvestingPro indicates the trailing one-year performance registers at 267%, with shares currently hovering within 1% of their 52-week peak of $273.50.
This impressive rally has been underpinned by robust financial performance and a wave of bullish analyst revisions in recent weeks.
Lam delivered third-quarter fiscal results that exceeded both Stifel’s projections and Wall Street consensus. Additionally, the semiconductor equipment manufacturer provided fourth-quarter guidance that topped analyst expectations for both top-line growth and margin expansion.
Executives highlighted that the organization has already achieved its previously outlined financial framework for calendar 2028 and the years following — well ahead of the original timeline.
Wall Street Elevates Price Objectives
On Wednesday, TD Cowen’s Krish Sankar increased his LRCX price objective to $340 from $290 while maintaining a Buy designation. Sankar recognized that skeptics may highlight limited additional upside following the robust June quarter forecast and premium valuation multiples, yet he contends that solid customer demand and strong profitability metrics justify continued upward estimate revisions.
Stifel similarly upheld its Buy stance and elevated its price target to $325, referencing the company’s impressive quarterly performance.
RBC Capital increased its objective to $310, emphasizing robust demand stemming from generative AI applications and market share expansion, coupled with an enhanced projection for wafer fabrication equipment expenditures in 2026.
Cantor Fitzgerald maintained an Overweight rating alongside a $320 price target, highlighting an improved wafer fabrication equipment landscape extending through 2026 and 2027.
UBS reaffirmed its Buy rating, emphasizing Lam’s evolution into what analysts characterize as an AI-powered expansion phase.
Strong Fundamentals Support Rally
Lam’s core financial metrics have remained solid throughout the stock’s ascent. The company boasts an excellent Piotroski Score of 9, indicating robust financial health, while 20 analysts have adjusted their earnings projections upward during recent reporting periods, per InvestingPro data.
TD Cowen’s Sankar acknowledged that critics will cite elevated valuation multiples following the strong guidance, but the firm maintains that customer demand momentum and profitability trends continue to provide support.
LRCX concluded Thursday’s session up approximately 4%, with the stock positioned near its newly established all-time peak of $274.42.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
